WHO IS GOING TO GET MEDICAL CANNABIS ON THE NHS?

Olivia Newton-John is taking it for breast cancer. Ministers said it would be available to British patients this month. But with days to go, confusion reigns. So…

MEDICINAL cannabis is due to become available on the NHS this month – a move that experts say will help thousands of people with chronic conditions such as epilepsy and multiple sclerosis. But what will the relaxing of restrictions around treatments derived from the drug actually mean in practice? While there is a wide range of cannabis-derived medications to help control everything from seizures and anxiety to muscle spasms and chronic pain, knowing exactly what will be made available in the UK is a complex issue.

The Mail on Sunday can reveal there are already concerns about who will qualify for medicines, how they will be prescribed, and the benefits they will potentially bring. While many doctors have backed the policy change, others argue there is not yet enough evidence to allow medics to safely prescribe medicinal cannabis, and that some types could even impact a child’s brain development.

There is also confusion over the definition of medicinal cannabis, what it contains, and for which conditions it will be considered as a treatment.

Last week, Grease actress Olivia Newton-John revealed she was taking cannabis oil to aid sleep and reduce pain after suffering a third relapse in her battle against breast cancer. Her oil comes from marijuana plants grown by her husband John Easterling in California, where laws are so relaxed that even recreational use of cannabis is legal.

But how will things change for patients here, and what could it mean for you and your family?

LANDMARK DECISION, THEN CONFUSION

UNTIL recently, cannabis was deemed by the Home Office to have ‘no recognised medicinal benefit’. Yet Dame Sally Davies, the Chief Medical Officer for England, who carried out the first part of the Government’s review that led to the policy change, overrode this, referring to ‘conclusive evidence’ to the contrary. In July the Home Office said: ‘The Home Secretary has pledged that the law will be changed by the autumn so that specialist clinicians will be able to legally prescribe cannabisderived medicinal products to patients with an exceptional clinical need.’

The change in the law, which will also apply in Scotland, follows a long battle by campaigners and patients, including parents who say that medicines derived from the plant – and prescribed overseas where laws are different – have transformed their children’s lives.

Among those treated with cannabis oil – a liquid containing compounds derived from the cannabis plant – are Billy Caldwell, 13, and Alfie Dingley, six, who both have severe epilepsy .

Billy’s plight was first reported by The Mail on Sunday, and the teenager from Northern Ireland and his mother Charlotte became the focus of the crusade to change the law after his medication was confiscated at Heathrow Airport. Mrs Caldwell had been attempting to bring in oil from Canada.

Both Billy and Alfie have since been granted a lifetime licence for the cannabis oil they take.

In June, the Government set up an expert panel, including scientists and neurologists, to consider licence applications for the use of cannabis in cases of ‘exceptional medical need’.

But apart from Billy and Alfie, only Sophia Gibson, seven, who also has a severe form of epilepsy, has been granted a licence.

Tory MP Sir Mike Penning warned the Home Secretary earlier this month: ‘There is now a serious risk that the much-welcomed panel may soon become a focus of disappointment if it is seen to only help a very small number of patients.’

The panel must consider whether the product has already been effective for the patient in question – meaning the family should already have had access to cannabis products from other countries. Sir Mike says this is ‘highly unfair’ and ‘heavily favours patients in the financial and physical position to be able to undertake such a costly and stressful trip’. Patients must have also exhausted all other treatment options, which neurologist Professor Mike Barnes, who treated Alfie, says is ‘crazy’ because there are more than 20 anti-epilepsy drugs for children.

Alfie’s mother, Hannah Deacon, who works with medical cannabis campaign group End Our Pain, claims they had heard from 16 families who had been unable to secure a licence for their children, primarily because they have not received the necessary backing from their local NHS trust or clinicians.

SLOW STEPS TO CHANGE

THE cannabis plant contains hundreds of naturally occurring compounds called cannabinoids.

The best known of these are cannabidiol (CBD) and tetrahydrocannabinol (THC).

The term medicinal cannabis broadly refers to products containing one or more of these compounds. They are usually oils taken orally or as capsules. There is a wide range of these medicines, manufactured mainly by small companies in Canada, the US and Netherlands, where the laws around these drugs are different. Patients in the UK have been accessing the products by travelling to these countries.

Last night the Home Office could not confirm which kinds, if any, of cannabis oils will become legal in the UK. And the British Paediatric Neurology Association (BPNA), which represents doctors caring for children with disorders such as epilepsy, has warned that tests show the contents of many products marketed as medicinal cannabis vary from batch to batch, which will make approving them for medical use difficult, if not impossible.

At present, a scheduling system determines the therapeutic value of all drugs. Those in the highest category – Schedule 1 – are heavily restricted because they are believed to have no medical value,